Physician profile
Christopher M Lowery
NPI 1679512743
$3,413.75
in general payments reported to CMS, 2019-2025
10 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $14.54 · 2021: $115 · 2022: $374 · 2023: $1,374 · 2024: $573 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,674.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,072.81 | 2019-2025 | Rhythmia Mapping System, Farapulse, General - Therapies |
| Biosense Webster, INC. | $679.68 | 2022-2025 | Carto 3, Pentaray Nav, Qdot Micro Catheter |
| Impulse Dynamics (USA) INC. | $563.93 | 2023 | Optimizer |
| Medtronic, INC. | $447.16 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Linq II, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $219.60 | 2023-2025 | Ensite, Gallant |
| Atricure, INC. | $174.85 | 2023-2024 | Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic Vascular, INC. | $164.31 | 2019 | |
| Baylis Medical Company INC | $49.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $26.25 | 2025 | |
| Vifor Pharma, INC. | $15.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lowery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.